SCHEMBL9212340

SCHEMBL9212340

Cc1nc2cc(-c3ccccc3)nn2c(Cl)c1CCCl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
HPGD P15428 4/20 0.55
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NFKB1 P19838 1/20 0.55
HTT P42858 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
DPP4 P27487 4/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
KDM4E B2RXH2 3/20 0.54
MAPT P10636 7/20 0.52
POLB P06746 1/20 0.49
GAA P10253 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
DPP8 Q6V1X1 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9210449 0.84 ALDH1A1 (0.42) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL5052689 0.81 NPC1 (0.62) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL5826439 0.81 DPP4 (0.46) NPC1RAB9AHPGDSMN1; SMN2HTT
SCHEMBL459359 0.79 MAPT (0.52) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL1664978 0.79 NPC1 (0.58) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL15191540 0.76 NPC1 (0.56) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL15570091 0.74 NPC1 (0.55) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL21775472 0.74 MAPT (0.57) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL7063800 0.74 RAB9A (0.71) NPC1RAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL13258606 0.73 NPC1 (0.67) NPC1RAB9AHPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0508549-B1 New triazolopyrimidine and pyrazolopyrimidine derivatives useful for treating cachexia SANKYO CO (JP) 1995-04-26 EP disclosed
EP-0347252-B1 METHOD OF TREATING CACHEXIA AND CERTAIN NEW COMPOUNDS FOR USE IN THIS METHOD SANKYO COMPANY LIMITED (JP) 1993-05-05 EP disclosed
EP-0508549-A2 New triazolopyrimidine and pyrazolopyrimidine derivatives useful for treating cachexia SANKYO COMPANY LIMITED (JP) 1992-10-14 EP disclosed
US-5086057-A METHOD OF TREATING CACHEXIA AND CERTAIN NEW COMPOUNDS FOR USE IN THIS METHOD SANKYO COMPANY LIMITED (JP) 1992-02-04 US disclosed
US-5055479-A For enhancing activity of lipoprotein lipase enzymes SANKYO COMPANY, LIMITED (JP) 1991-10-08 US disclosed
US-4992442-A Bronchodilator agents POLA CHEMICAL INDUSTRIES INC., JAPAN (JP) 1991-02-12 US disclosed
EP-0347252-A2 Method of treating cachexia and certain new compounds for use in this method SANKYO COMPANY LIMITED (JP) 1989-12-20 EP disclosed